Aurobindo Pharma acquires Pharmacin International B.V

RELATED NEWS Aurobindo Pharma buys Dutch firm Pharmacin Aurobindo Pharma can easily go upto Rs 750 Aurobindo Pharma set to acquire Senor Organics Aurobindo receives another approval from MCC South Africa Aurobindo posts landmark results in Q2 ALSO READ See latest News about Aurobindo Pharm See previous management interviews See what other Experts & Brokerages are saying about Aurobindo Pharm Aurobindo Pharm BSE | NSE 10/02/12 Are Mutual Funds betting on Aurobindo Pharm?

Aurobindo Pharma Ltd , through its wholly owned subsidiary Agile Pharma B.V, Netherlands, has entered into Share Purchase Agreement with Jerim B.V.. and Jonghoud International B.V. to acquire Netherlands based generic pharmaceutical company, Pharmacin International B.V.

 

Under the terms of the share purchase agreement, Agile Pharma B.V. has acquired 100% of the shares of Pharmacin International B.V. from Jerim B.V. and Jonghoud International B.V.

 

Pharmacin is a profit making generic pharmaceutical company with a sale of over Euro 6 million for the year ended Dec 2006, with a CAGR of over 30%. Pharmacin is engaged in the business of supply and licensing of generic pharmaceuticals in Netherlands and in select key markets in Europe. Pharmacin owns several product dossiers/market authorizations and IPR.

 

Pharmacin has a broad product portfolio in three key segments - CNS, CVS and Gasteroenterologicals and the dossiers support over 200 product registrations for 63 customers in Netherlands and Europe. Pharmacin has a reach into most parts of Europe. In addition, Pharmacin has continuously invested in enhancing the product portfolio and certain key product registrations are awaited in the coming months augmenting the business.

 

Contd on page 2....